About Pricing FAQs Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Ultrasound Quantification of Liver Fat | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT04523584

Ultrasound Quantification of Liver Fat

The investigators plan a prospective study designed to evaluate the accuracy of a new ultrasound method for quantification of liver fat content.

Lead sponsor: Children's Hospital Medical Center, Cincinnati•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Children's Hospital Medical Center, Cincinnati

Collaborators

Siemens Medical Solutions

MRI proton density fat fraction (PDFF) will serve as the reference standard for liver fat fraction measurements. The strength of agreement between ultrasound derived fat fraction (UDFF) and PDFF will be the outcome of interest for this study.

Age

16 - No limit years

Sex

ALL

Healthy Volunteers

No

Inclusion Criteria

•Patients 16 years of age or older with known fatty liver disease (based upon prior MRI or ultrasound), or at risk for fatty liver disease (obese).

Exclusion Criteria

•Subject under the age of 16
•Pregnant subject
•Subjects who cannot cooperate with performance of the ultrasound exam
•Subjects who cannot cooperate with performance of the MRI exam
•Subjects who have contraindications to MRI
•Subjects who might require sedation or anesthesia to undergo study imaging

Related studies

CHronic Hepatopathies Associated With ALcohol Consumption aNd metAbolic Syndrome

NCT05623150 · Non-Alcoholic Fatty Liver Disease, Non-Alcoholic Steatohepatitis, and more

Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease

NCT07265544 · Liver Neoplasm, HBV Infection, and more

RECRUITINGPhase 1

Effect of Insulin Lowering on Lipogenesis

NCT07403604 · Hyperinsulinemia, Insulin Resistance, and more

Liver-gut Axis Study Through Identification of Liver Disease-specific Microbiome

NCT06519162 · Autoimmune Hepatitis, Primary Sclerosing Cholangitis, and more

Identification of Liver Fibrosis Biomarkers

NCT06819917 · Non-alcoholic Fatty Liver, Non-Alcoholic Fatty Liver Disease, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: July 25, 2022Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment192

Start dateNov 2016

Last updatedJul 25, 2022

Condition

Non-Alcoholic Fatty Liver Disease

Locations shown

Cincinnati Children's Hospital Medical Center

Cincinnati, Ohio

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: July 25, 2022Data synced to Clareo: June 28, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions